Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 31, 2015 4:47 PM ET


Company Overview of Cubist Pharmaceuticals Inc.

Executive Profile

Nancy June Hutson Ph.D.

Director and Chairman of Corporate Governance & Nominating Committee, BioCryst Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 7 different industries.

See Board Relationships


Dr. Nancy June Hutson, Ph.D., is a Member of Scientific Advisory Board at Hatteras Venture Partners. She served as Senior Vice President of R&D for Groton and New London Campuses at BioCryst Pharmaceuticals, Inc. until March 2006. Dr. Hutson was a Sponsor of the Network of Executive Women, where she served as a mentor for senior women at Pfizer Global Research & Development. She retired from Pfizer, Inc. in 2006 after spending 25 years in several research and leadership ...

Corporate Headquarters

65 Hayden Avenue
Lexington, Massachusetts 02421

United States

Phone: 781-860-8660
Fax: --

Board Members Memberships

Director, Chairperson of Development Committee and Member of Compensation Committee
Former Director, Chairman of Corporate Governance & Nominating Committee and Member of Scientific Affairs Committee
Independent Director, Chairman of Operations Committee and Member of Nominating & Governance Committee
Director, Member of Compensation Committee and Member of Transactions Committee
Director and Chairman of Corporate Governance & Nominating Committee


Vanderbilt University
Vanderbilt University
Illinois Wesleyan University
University of Oxford

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$36,000
Total Calculated Compensation$54,305

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Gustav A. Christensen Chief Executive Officer, President and Director
Dyax Corp.
Sijmen de Vries M.D., MBAChief Executive Officer and Member of Management Board
Pharming Group NV
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
Thomas W. D'Alonzo Esq., J.D.Chairman, Acting Chief Executive Officer, Acting President, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee
Salix Pharmaceuticals Ltd.
Joji Nakayama Chief Executive Officer, President and Representative Director
Daiichi Sankyo Company, Limited
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cubist Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at